587 - 68Ga-PSMA-11 PET/CT detects prostate cancer at early biochemical recurrence with superior detection rate and reader agreement when compared to 18F-Fluciclovine PET/CT in a prospective head-to-head comparative phase 3 study< (ID 1281)
Session Name
69 - Prostate Diagnosis I
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> GU
Presentation Number
587
1009 - A new PET imaging agent for monitoring HER2 status using Trastuzumab antibody conjugated with a novel 89 Zr-chelator. (ID 61)
Session Name
Preclinical Probes for Oncology Posters
Speakers
Presentation Topic
Molecular Targeting Probes - Radioactive & Nonradioactive -> Preclinical Probes for Oncology
Presentation Number
1009
2006 - Added Value of Digital over Analog PET: A Technologist Perspective (ID 263)
Session Name
TS07 - Tech Papers I: Clinical PET
Speakers
Authors
Presentation Topic
Clinical PET
Presentation Number
2006
1423 - Association of gastric wall tracer uptake with proton pump inhibitor use in patients undergoing 99mTc-sestamibi myocardial perfusion scintigraphy (ID 1105)
Session Name
Cardiovascular Clinical Science Posters
Speakers
Presentation Topic
Cardiovascular -> Clinical Science
Presentation Number
1423
217 - Close correlation in cancer patients between diffusely decreased liver uptake on FDG-PET & cancer-associated cachexia (ID 919)
Session Name
27 - GI ? Colorectal, Liver, Esophageal
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Diagnosis -> GI – Colorectal and Liver
Presentation Number
217
351 - Combination of 177Lu-lilotomab satetraxetan with rituximab synergistically improves in-vivo therapeutic efficacy in a rituximab-resistant non-Hodgkin lymphoma (NHL) model (ID 1000)
Session Name
42 - Oncology, Basic and Translational (Basic Science) III
Speakers
Presentation Topic
Neurosciences -> Basic Science
Presentation Number
351
77 - Combined PRLT using Ac-225 and Lu-177 labeled PSMA-617 (TANDEM-PRLT) in end-stage metastatic prostate cancer: a concept to reduce salivary gland toxicity? (ID 421)
Session Name
10 - Center for Therapy Excellence YIA Symposium
Speakers
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy -> Prostate/GU
Presentation Number
77
1622 - Design and Synthesis of a Novel Class of Theranostic Small-Molecule Drug Conjugates for Targeted Drug Delivery and Controlled Release (ID 1374)
Session Name
Radiochemistry & Chelation Posters
Speakers
Authors
Presentation Topic
Molecular Targeting Probes - Radioactive & Nonradioactive -> Novel Radiochemistry & Chelation
Presentation Number
1622
Molecular Targeting Probes - Radioactive & Nonradioactive -> Novel Multimodality and Nonradioactive Probes
1177
1177 - Detection of Metabolic Changes using Hyperpolarized 13C MRI in a Negative 18F-FDG PET Rat Brain Cancer Model (ID 451)
Session Name
Novel Multimodality and Nonradioactive Probes Posters
Speakers
Presentation Topic
Molecular Targeting Probes - Radioactive & Nonradioactive -> Novel Multimodality and Nonradioactive Probes
Presentation Number
1177
1523 - Development of a Grading System Based on Dual Molecular Imaging with Ga-DOTATATE and FDG PET/CT in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Neoplasias. (ID 1232)
Session Name
Endocrinology (Clinical Therapy) Posters
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy -> Endocrinology/Neuroendocrine
Presentation Number
1523